State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage — United States, 2008–2014

@inproceedings{Singleterry2014StateMC,
  title={State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage — United States, 2008–2014},
  author={Jennifer Singleterry and Zach Jump and Elizabeth A Lancet and Stephen D. Babb and Allison MacNeil and L Zhang},
  booktitle={MMWR. Morbidity and mortality weekly report},
  year={2014}
}
Medicaid enrollees have a higher smoking prevalence than the general population (30.1% of adult Medicaid enrollees aged <65 years smoke, compared with 18.1% of U.S. adults of all ages), and smoking-related disease is a major contributor to increasing Medicaid costs. Evidence-based cessation treatments exist, including individual, group, and telephone counseling and seven Food and Drug Administration (FDA)-approved medications. A Healthy People 2020 objective (TU-8) calls for all state Medicaid… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…